The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
A Controlled Trial of Nimodipine in Acute Ischemic Stroke
Abstract
Recent investigations suggest that increased cellular calcium concentrations may be implicated in neuronal death after ischemia. To determine whether treatment with a calcium-channel blocker would improve survival and neurologic outcome in acute ischemic stroke, we enrolled 186 patients in a prospective, double-blind, randomized, placebo-controlled trial of nimodipine (30 mg every six hours), begun within 24 hours of the onset of symptoms of an acute ischemic stroke. During the four-week treatment period, mortality from all causes was significantly reduced with nimodipine as compared with placebo (8 deaths [8.6 percent] vs. 19 [20.4 percent]). The improvement in survival was restricted to men. During the follow-up period of six months, an additional eight patients in each group died. A significantly better neurologic outcome, as assessed by the Mathew scale of neurologic deficit, was also observed in the nimodipine group. The improvement in neurologic status was greatest in patients with a moderate to severe deficit at base line. There were no important side effects except for one episode of reversible azotemia that may have been related to treatment with nimodipine. Our data suggest that patients with acute ischemic stroke may benefit from early treatment with nimodipine, but this therapeutic effect appears to be limited to men.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DOUBLE-BLIND EVALUATION OF GLYCEROL THERAPY IN ACUTE CEREBRAL INFARCTION
Mathew, N., Rivera, V., Meyer, J., Charney, J., & Hartmann, A. (1972) · The Lancet · doi:10.1016/s0140-6736(72)92775-4 · Cited by 242
Gotoh, O., Mohamed, A. A., McCulloch, J., Graham, D. I., Harper, A. M., & Teasdale, G. M. (1986) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1986.55 · Cited by 145
The effects of nimodipine on the clinical course of patients with acute ischemic stroke
Gelmers, H. J. (1984) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1984.tb07806.x · Cited by 141
Self-citationPossible role of calcium blockers in cerebral resuscitation
White, B. C., Winegar, C. D., Wilson, R. F., Hoehner, P. J., & Trombley, J. H. (1983) · Critical Care Medicine · doi:10.1097/00003246-198303000-00013 · Cited by 108
[Development of a neurological score for the clinical evaluation of sylvian infarctions].
Orgogozo, J. M., Capildeo, R., Anagnostou, C. N., Juge, O., Péré, J.-J., Dartigues, J. F., Steiner, T. J., Yotis, A., & Rose, F. C. (1983) · PubMed · Cited by 44
Cited by
The Risk of Determining Risk with Multivariable Models
Concato, J., Feinstein, A. R., & Holford, T. R. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-3-199302010-00009 · Cited by 1,115
Neuroprotection for ischemic stroke: Past, present and future
Ginsberg, M. D. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.12.007 · Cited by 779
Ebselen in Acute Ischemic Stroke: A Placebo-Controlled, Double-blind Clinical Trial
Yamaguchi, T., Sano, K., Takakura, K., Saito, I., Shinohara, Y., Asano, T., & Yasuhara, H. (1998) · Stroke · doi:10.1161/01.str.29.1.12 · Cited by 610
Adams, H. P., Brott, T. G., Crowell, R. M., Furlan, A. J., Gomez, C. R., Grotta, J., Helgason, C. M., Marler, J. R., Woolson, R. F., & Zivin, J. A. (1994) · Stroke · doi:10.1161/01.str.25.9.1901 · Cited by 488
Duncan, P. W., Jorgensen, H. S., & Wade, D. T. (2000) · Stroke · doi:10.1161/01.str.31.6.1429 · Cited by 484
Metadata
- Authors
- Gelmers, H. J., Gorter, K., de Weerdt, C. J., & Wiezer, H. J. A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1988-01-28
- Volume
- 318
- Issue
- 4
- Pages
- 203-207
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2336161314
- Cited by
- 419
- References
- 5
- FWCI
- 45.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Controlled Trial of Nimodipine in Acute Ischemic Stroke. https://app.cochat.ai/papers/10.1056/nejm198801283180402
- The paper
- Gelmers, H. J., Gorter, K., de Weerdt, C. J., & Wiezer, H. J. A. (1988). A Controlled Trial of Nimodipine in Acute Ischemic Stroke. New England Journal of Medicine. https://doi.org/10.1056/nejm198801283180402
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.